{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:35:40Z","timestamp":1793424940042,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Blood Cancer UK Specialist Programme Grant 13001 NIHR Oxford Biomedical Centre Research Fund"},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA175737"],"award-info":[{"award-number":["R01CA175737"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["3R01CA175737-05S1"],"award-info":[{"award-number":["3R01CA175737-05S1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA175737"],"award-info":[{"award-number":["R01CA175737"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["3R01CA175737-05S1"],"award-info":[{"award-number":["3R01CA175737-05S1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["3R01CA175737-05S1"],"award-info":[{"award-number":["3R01CA175737-05S1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100012117","name":"Lady Tata Memorial Trust","doi-asserted-by":"publisher","award":["Lady Tata Memorial International Fellowship"],"award-info":[{"award-number":["Lady Tata Memorial International Fellowship"]}],"id":[{"id":"10.13039\/100012117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["Wellcome Clinical Research Career Development Fellowship (216632\/Z\/19\/Z)"],"award-info":[{"award-number":["Wellcome Clinical Research Career Development Fellowship (216632\/Z\/19\/Z)"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Blood Cancer UK Clinician Scientist Fellowship"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100001445","name":"Alex\u2019s Lemonade Stand Foundation for Childhood Cancer","doi-asserted-by":"publisher","award":["\u2018A\u2019 Award"],"award-info":[{"award-number":["\u2018A\u2019 Award"]}],"id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Down syndrome is associated with genome-wide perturbation of gene expression, which may be mediated by epigenetic changes. We perform an epigenome-wide association study on neonatal bloodspots comparing 196 newborns with Down syndrome and 439 newborns without Down syndrome, adjusting for cell-type heterogeneity, which identifies 652 epigenome-wide significant CpGs (<jats:italic>P<\/jats:italic>\u2009&lt;\u20097.67\u2009\u00d7\u200910<jats:sup>\u22128<\/jats:sup>) and 1,052 differentially methylated regions. Differential methylation at promoter\/enhancer regions correlates with gene expression changes in Down syndrome versus non-Down syndrome fetal liver hematopoietic stem\/progenitor cells (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). The top two differentially methylated regions overlap <jats:italic>RUNX1<\/jats:italic> and <jats:italic>FLI1<\/jats:italic>, both important regulators of megakaryopoiesis and hematopoietic development, with significant hypermethylation at promoter regions of these two genes. Excluding Down syndrome newborns harboring preleukemic <jats:italic>GATA1<\/jats:italic> mutations (<jats:italic>N<\/jats:italic>\u2009=\u200930), identified by targeted sequencing, has minimal impact on the epigenome-wide association study results. Down syndrome has profound, genome-wide effects on DNA methylation in hematopoietic cells in early life, which may contribute to the high frequency of hematological problems, including leukemia, in children with Down syndrome.<\/jats:p>","DOI":"10.1038\/s41467-021-21064-z","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T11:24:30Z","timestamp":1612524270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis"],"prefix":"10.1038","volume":"12","author":[{"given":"Ivo S.","family":"Muskens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0544-5338","authenticated-orcid":false,"given":"Shaobo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalina","family":"Elliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swe Swe","family":"Myint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyatama","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M.","family":"Schraw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Anguiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Goudevenou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7599-9726","authenticated-orcid":false,"given":"Kimberly D.","family":"Siegmund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4934-4125","authenticated-orcid":false,"given":"Marella F. T. R.","family":"de Bruijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5879-9981","authenticated-orcid":false,"given":"Kyle M.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3931-0914","authenticated-orcid":false,"given":"Paresh","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8607-5748","authenticated-orcid":false,"given":"Anindita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Wiemels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4880-7543","authenticated-orcid":false,"given":"Adam J.","family":"de Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"21064_CR1","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/bdra.20735","volume":"88","author":"SE Parker","year":"2010","unstructured":"Parker, S. E. et al. Updated national birth prevalence estimates for selected birth defects in the United States, 2004\u20132006. Birth Defects Res. A. Clin. Mol. Teratol. 88, 1008\u20131016 (2010).","journal-title":"Birth Defects Res. A. Clin. Mol. Teratol."},{"key":"21064_CR2","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1073\/pnas.91.11.4997","volume":"91","author":"JR Korenberg","year":"1994","unstructured":"Korenberg, J. R. et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc. Natl. Acad. Sci. U. S. A. 91, 4997\u20135001 (1994).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"21064_CR3","doi-asserted-by":"publisher","first-page":"17579","DOI":"10.1073\/pnas.1211405109","volume":"109","author":"A Roy","year":"2012","unstructured":"Roy, A. et al. Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. Proc. Natl Acad. Sci. U. S. A. 109, 17579\u201317584 (2012).","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"21064_CR4","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jpeds.2005.07.022","volume":"147","author":"YC de Hingh","year":"2005","unstructured":"de Hingh, Y. C. et al. Intrinsic abnormalities of lymphocyte counts in children with down syndrome. J. Pediatr. 147, 744\u2013747 (2005).","journal-title":"J. Pediatr."},{"key":"21064_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2249.2011.04335.x","volume":"164","author":"G Ram","year":"2011","unstructured":"Ram, G. & Chinen, J. Infections and immunodeficiency in Down syndrome. Clin. Exp. Immunol. 164, 9\u201316 (2011).","journal-title":"Clin. Exp. Immunol."},{"key":"21064_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","volume":"355","author":"H Hasle","year":"2000","unstructured":"Hasle, H., Clemmensen, I. H. & Mikkelsen, M. Risks of leukaemia and solid tumours in individuals with Down\u2019s syndrome. Lancet 355, 165\u2013169 (2000).","journal-title":"Lancet"},{"key":"21064_CR7","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/gim.2016.23","volume":"18","author":"H Hasle","year":"2016","unstructured":"Hasle, H., Friedman, J. M., Olsen, J. H. & Rasmussen, S. A. Low risk of solid tumors in persons with Down syndrome. Genet. Med. 18, 1151\u20131157 (2016).","journal-title":"Genet. Med."},{"key":"21064_CR8","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1182\/blood-2013-07-515148","volume":"122","author":"I Roberts","year":"2013","unstructured":"Roberts, I. et al. GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia. Blood 122, 3908\u20133917 (2013).","journal-title":"Blood"},{"key":"21064_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11899-016-0338-x","volume":"11","author":"N Bhatnagar","year":"2016","unstructured":"Bhatnagar, N., Nizery, L., Tunstall, O., Vyas, P. & Roberts, I. Transient abnormal myelopoiesis and AML in Down Syndrome: an update. Curr. Hematol. Malig. Rep. 11, 333\u2013341 (2016).","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"21064_CR10","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1182\/blood-2007-10-118810","volume":"111","author":"JH Klusmann","year":"2008","unstructured":"Klusmann, J. H. et al. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood 111, 2991\u20132998 (2008).","journal-title":"Blood"},{"key":"21064_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrg.2016.154","volume":"18","author":"SE Antonarakis","year":"2017","unstructured":"Antonarakis, S. E. Down syndrome and the complexity of genome dosage imbalance. Nat. Rev. Genet. 18, 147\u2013163 (2017).","journal-title":"Nat. Rev. Genet."},{"key":"21064_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature13200","volume":"508","author":"A Letourneau","year":"2014","unstructured":"Letourneau, A. et al. Domains of genome-wide gene expression dysregulation in Down\u2019s syndrome. Nature 508, 345\u2013350 (2014).","journal-title":"Nature"},{"key":"21064_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.15252\/embr.201439583","volume":"16","author":"B Liu","year":"2015","unstructured":"Liu, B., Filippi, S., Roy, A. & Roberts, I. Stem and progenitor cell dysfunction in human trisomies. EMBO Rep. 16, 44\u201362 (2015).","journal-title":"EMBO Rep."},{"key":"21064_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1086\/519248","volume":"81","author":"P Prandini","year":"2007","unstructured":"Prandini, P. et al. Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance. Am. J. Hum. Genet. 81, 252\u2013263 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"21064_CR15","doi-asserted-by":"publisher","first-page":"e1001212","DOI":"10.1371\/journal.pgen.1001212","volume":"6","author":"K Kerkel","year":"2010","unstructured":"Kerkel, K. et al. Altered DNA methylation in leukocytes with trisomy 21. PLoS Genet. 6, e1001212 (2010).","journal-title":"PLoS Genet."},{"key":"21064_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.18632\/aging.100715","volume":"7","author":"MG Bacalini","year":"2015","unstructured":"Bacalini, M. G. et al. Identification of a DNA methylation signature in blood cells from persons with Down Syndrome. Aging 7, 82\u201396 (2015).","journal-title":"Aging"},{"key":"21064_CR17","doi-asserted-by":"publisher","first-page":"e0194938","DOI":"10.1371\/journal.pone.0194938","volume":"13","author":"P Henneman","year":"2018","unstructured":"Henneman, P. et al. Widespread domain-like perturbations of DNA methylation in whole blood of Down syndrome neonates. PLoS ONE 13, e0194938 (2018).","journal-title":"PLoS ONE"},{"key":"21064_CR18","doi-asserted-by":"crossref","unstructured":"Mendioroz, M. et al. Trans effects of chromosome aneuploidies on DNA methylation patterns in human Down syndrome and mouse models. Genome Biol. 16, 263 (2015).","DOI":"10.1186\/s13059-015-0827-6"},{"key":"21064_CR19","doi-asserted-by":"publisher","first-page":"e0135555","DOI":"10.1371\/journal.pone.0135555","volume":"10","author":"MR Sailani","year":"2015","unstructured":"Sailani, M. R. et al. DNA-methylation patterns in trisomy 21 using cells from monozygotic twins. PLoS ONE 10, e0135555 (2015).","journal-title":"PLoS ONE"},{"key":"21064_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1471-0528.1993.tb12952.x","volume":"100","author":"B Thilaganathan","year":"1993","unstructured":"Thilaganathan, B., Tsakonas, D. & Nicolaides, K. Abnormal fetal immunological development in Down\u2019s syndrome. Br. J. Obstet. Gynaecol. 100, 60\u201362 (1993).","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"21064_CR21","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/s41588-019-0494-8","volume":"51","author":"I Jung","year":"2019","unstructured":"Jung, I. et al. A compendium of promoter-centered long-range chromatin interactions in the human genome. Nat. Genet. 51, 1442\u20131449 (2019).","journal-title":"Nat. Genet."},{"key":"21064_CR22","doi-asserted-by":"publisher","unstructured":"Grassi, L. et al. Cell type specific novel lncRNAs and circRNAs in the BLUEPRINT haematopoietic transcriptomes atlas. Haematologica https:\/\/doi.org\/10.3324\/haematol.2019.238147 (2020).","DOI":"10.3324\/haematol.2019.238147"},{"key":"21064_CR23","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/ng.2949","volume":"46","author":"AA Lane","year":"2014","unstructured":"Lane, A. A. et al. Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation. Nat. Genet. 46, 618\u2013623 (2014).","journal-title":"Nat. Genet."},{"key":"21064_CR24","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nature07619","volume":"457","author":"MJ Chen","year":"2009","unstructured":"Chen, M. J., Yokomizo, T., Zeigler, B. M., Dzierzak, E. & Speck, N. A. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 457, 887\u2013891 (2009).","journal-title":"Nature"},{"key":"21064_CR25","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1111\/cas.14160","volume":"110","author":"Y Kubota","year":"2019","unstructured":"Kubota, Y. et al. Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome. Cancer Sci. 110, 3358\u20133367 (2019).","journal-title":"Cancer Sci."},{"key":"21064_CR26","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1093\/nar\/23.14.2762","volume":"23","author":"H Miyoshi","year":"1995","unstructured":"Miyoshi, H. et al. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res. 23, 2762\u20132769 (1995).","journal-title":"Nucleic Acids Res."},{"key":"21064_CR27","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1182\/blood-2009-08-238626","volume":"115","author":"T Bee","year":"2010","unstructured":"Bee, T. et al. Nonredundant roles for Runx1 alternative promoters reflect their activity at discrete stages of developmental hematopoiesis. Blood 115, 3042\u20133050 (2010).","journal-title":"Blood"},{"key":"21064_CR28","doi-asserted-by":"publisher","first-page":"5279","DOI":"10.1182\/blood-2009-05-222307","volume":"114","author":"P Sroczynska","year":"2009","unstructured":"Sroczynska, P., Lancrin, C., Kouskoff, V. & Lacaud, G. The differential activities of Runx1 promoters define milestones during embryonic hematopoiesis. Blood 114, 5279\u20135289 (2009).","journal-title":"Blood"},{"key":"21064_CR29","doi-asserted-by":"publisher","unstructured":"Lie-A-Ling, M. et al. Regulation of RUNX1 dosage is crucial for efficient blood formation from hemogenic endothelium. Development 145, https:\/\/doi.org\/10.1242\/dev.149419 (2018).","DOI":"10.1242\/dev.149419"},{"key":"21064_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1074-7613(00)00042-X","volume":"13","author":"Z Cai","year":"2000","unstructured":"Cai, Z. et al. Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo. Immunity 13, 423\u2013431 (2000).","journal-title":"Immunity"},{"key":"21064_CR31","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1182\/blood-2013-03-489369","volume":"122","author":"BR Webber","year":"2013","unstructured":"Webber, B. R. et al. DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo. Blood 122, 2978\u20132986 (2013).","journal-title":"Blood"},{"key":"21064_CR32","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1182\/blood.V93.8.2637","volume":"93","author":"LS Bastian","year":"1999","unstructured":"Bastian, L. S., Kwiatkowski, B. A., Breininger, J., Danner, S. & Roth, G. Regulation of the megakaryocytic glycoprotein IX promoter by the oncogenic Ets transcription factor Fli-1. Blood 93, 2637\u20132644 (1999).","journal-title":"Blood"},{"key":"21064_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1074-7613(00)00017-0","volume":"13","author":"A Hart","year":"2000","unstructured":"Hart, A. et al. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 13, 167\u2013177 (2000).","journal-title":"Immunity"},{"key":"21064_CR34","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1128\/MCB.23.10.3427-3441.2003","volume":"23","author":"M Eisbacher","year":"2003","unstructured":"Eisbacher, M. et al. Protein\u2013protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA binding. Mol. Cell. Biol. 23, 3427\u20133441 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"21064_CR35","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1128\/MCB.00090-09","volume":"29","author":"H Huang","year":"2009","unstructured":"Huang, H. et al. Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. Mol. Cell. Biol. 29, 4103\u20134115 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"21064_CR36","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1101\/gr.164178.113","volume":"24","author":"M Pimkin","year":"2014","unstructured":"Pimkin, M. et al. Divergent functions of hematopoietic transcription factors in lineage priming and differentiation during erythro-megakaryopoiesis. Genome Res. 24, 1932\u20131944 (2014).","journal-title":"Genome Res."},{"key":"21064_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1172\/JCI21197","volume":"114","author":"H Raslova","year":"2004","unstructured":"Raslova, H. et al. FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau\/Jacobsen thrombopenia. J. Clin. Invest. 114, 77\u201384 (2004).","journal-title":"J. Clin. Invest."},{"key":"21064_CR38","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1182\/blood-2013-06-506873","volume":"122","author":"J Stockley","year":"2013","unstructured":"Stockley, J. et al. Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects. Blood 122, 4090\u20134093 (2013).","journal-title":"Blood"},{"key":"21064_CR39","doi-asserted-by":"publisher","unstructured":"Bergiers, I. et al. Single-cell transcriptomics reveals a new dynamical function of transcription factors during embryonic hematopoiesis. Elife 7, https:\/\/doi.org\/10.7554\/eLife.29312 (2018).","DOI":"10.7554\/eLife.29312"},{"key":"21064_CR40","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1080\/15592294.2019.1609867","volume":"14","author":"BI Laufer","year":"2019","unstructured":"Laufer, B. I., Hwang, H., Vogel Ciernia, A., Mordaunt, C. E. & LaSalle, J. M. Whole genome bisulfite sequencing of Down syndrome brain reveals regional DNA hypermethylation and novel disorder insights. Epigenetics 14, 672\u2013684 (2019).","journal-title":"Epigenetics"},{"key":"21064_CR41","doi-asserted-by":"publisher","first-page":"e0190789","DOI":"10.1371\/journal.pone.0190789","volume":"13","author":"H Fukui","year":"2018","unstructured":"Fukui, H., Runker, A., Fabel, K., Buchholz, F. & Kempermann, G. Transcription factor Runx1 is pro-neurogenic in adult hippocampal precursor cells. PLoS ONE 13, e0190789 (2018).","journal-title":"PLoS ONE"},{"key":"21064_CR42","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1523\/JNEUROSCI.5108-04.2005","volume":"25","author":"FM Theriault","year":"2005","unstructured":"Theriault, F. M. et al. Role for Runx1 in the proliferation and neuronal differentiation of selected progenitor cells in the mammalian nervous system. J. Neurosci. 25, 2050\u20132061 (2005).","journal-title":"J. Neurosci."},{"key":"21064_CR43","doi-asserted-by":"publisher","unstructured":"Jia, T. et al. Epigenome-wide meta-analysis of blood DNA methylation and its association with subcortical volumes: findings from the ENIGMA Epigenetics Working Group. Mol. Psychiatry,\u00a0https:\/\/doi.org\/10.1038\/s41380-019-0605-z\u00a0(2019).","DOI":"10.1038\/s41380-019-0605-z"},{"key":"21064_CR44","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ajhg.2011.03.019","volume":"88","author":"M Bakircioglu","year":"2011","unstructured":"Bakircioglu, M. et al. The essential role of centrosomal NDE1 in human cerebral cortex neurogenesis. Am. J. Hum. Genet. 88, 523\u2013535 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"21064_CR45","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1101\/gad.9.24.3136","volume":"9","author":"M Ishibashi","year":"1995","unstructured":"Ishibashi, M. et al. Targeted disruption of mammalian hairy and Enhancer of split homolog-1 (HES-1) leads to up-regulation of neural helix-loop-helix factors, premature neurogenesis, and severe neural tube defects. Genes Dev. 9, 3136\u20133148 (1995).","journal-title":"Genes Dev."},{"key":"21064_CR46","doi-asserted-by":"publisher","first-page":"e86356","DOI":"10.1371\/journal.pone.0086356","volume":"9","author":"M Inoue","year":"2014","unstructured":"Inoue, M. et al. Prdm8 regulates the morphological transition at multipolar phase during neocortical development. PLoS ONE 9, e86356 (2014).","journal-title":"PLoS ONE"},{"key":"21064_CR47","doi-asserted-by":"publisher","first-page":"F503","DOI":"10.1136\/adc.2006.104638","volume":"92","author":"D Webb","year":"2007","unstructured":"Webb, D., Roberts, I. & Vyas, P. Haematology of Down syndrome. Arch. Dis. Child. Fetal Neonatal Ed. 92, F503\u2013F507 (2007).","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"21064_CR48","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jpeds.2019.05.068","volume":"213","author":"I Nitzan","year":"2019","unstructured":"Nitzan, I. et al. Elevated nucleated red blood cells in neonates with Down syndrome and pulmonary hypertension. J. Pediatr. 213, 232\u2013234 (2019).","journal-title":"J. Pediatr."},{"key":"21064_CR49","doi-asserted-by":"publisher","first-page":"474","DOI":"10.5858\/2002-126-0474-TMDWED","volume":"126","author":"P Bozner","year":"2002","unstructured":"Bozner, P. Transient myeloproliferative disorder with erythroid differentiation in Down syndrome. Arch. Pathol. Lab. Med. 126, 474\u2013477 (2002).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"21064_CR50","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1182\/blood.2018890764","volume":"134","author":"AL Brown","year":"2019","unstructured":"Brown, A. L. et al. Inherited genetic susceptibility of acute lymphoblastic leukemia in Down syndrome. Blood\u00a0134, 1227\u20131237\u00a0(2019).","journal-title":"Blood"},{"key":"21064_CR51","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrg3152","volume":"13","author":"N Kim","year":"2012","unstructured":"Kim, N. & Jinks-Robertson, S. Transcription as a source of genome instability. Nat. Rev. Genet. 13, 204\u2013214 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"21064_CR52","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1084\/jem.20151920","volume":"213","author":"P Azad","year":"2016","unstructured":"Azad, P. et al. Senp1 drives hypoxia-induced polycythemia via GATA1 and Bcl-xL in subjects with Monge\u2019s disease. J. Exp. Med. 213, 2729\u20132744 (2016).","journal-title":"J. Exp. Med."},{"key":"21064_CR53","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/molehr\/7.8.765","volume":"7","author":"F Debieve","year":"2001","unstructured":"Debieve, F., Moiset, A., Thomas, K., Pampfer, S. & Hubinont, C. Vascular endothelial growth factor and placenta growth factor concentrations in Down\u2019s syndrome and control pregnancies. Mol. Hum. Reprod. 7, 765\u2013770 (2001).","journal-title":"Mol. Hum. Reprod."},{"key":"21064_CR54","doi-asserted-by":"crossref","unstructured":"Silver, M. J. et al. Independent genomewide screens identify the tumor suppressor VTRNA2-1 as a human epiallele responsive to periconceptional environment. Genome Biol. 16, 118 (2015).","DOI":"10.1186\/s13059-015-0660-y"},{"key":"21064_CR55","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1093\/hmg\/ddw043","volume":"25","author":"J Lu","year":"2016","unstructured":"Lu, J. et al. Global hypermethylation in fetal cortex of Down syndrome due to DNMT3L overexpression. Hum. Mol. Genet. 25, 1714\u20131727 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"21064_CR56","doi-asserted-by":"publisher","first-page":"e514","DOI":"10.3324\/haematol.2019.216465","volume":"104","author":"AB Nielsen","year":"2019","unstructured":"Nielsen, A. B. et al. Increased neonatal level of arginase 2 in cases of childhood acute lymphoblastic leukemia implicates immunosuppression in the etiology. Haematologica 104, e514\u2013e516 (2019).","journal-title":"Haematologica"},{"key":"21064_CR57","first-page":"e123","volume":"46","author":"W Zhou","year":"2018","unstructured":"Zhou, W., Triche, T. J. Jr, Laird, P. W. & Shen, H. SeSAMe: reducing artifactual detection of DNA methylation by Infinium BeadChips in genomic deletions. Nucleic Acids Res. 46, e123 (2018).","journal-title":"Nucleic Acids Res."},{"key":"21064_CR58","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1093\/nar\/gkt090","volume":"41","author":"TJ Triche Jr","year":"2013","unstructured":"Triche, T. J. Jr, Weisenberger, D. J., Van Den Berg, D., Laird, P. W. & Siegmund, K. D. Low-level processing of Illumina Infinium DNA Methylation BeadArrays. Nucleic Acids Res 41, e90 (2013).","journal-title":"Nucleic Acids Res"},{"key":"21064_CR59","doi-asserted-by":"publisher","unstructured":"Mah, C. K., Mesirov, J. P. & Chavez, L. An accessible GenePattern notebook for the copy number variation analysis of Illumina Infinium DNA methylation arrays. F1000Res 7, https:\/\/doi.org\/10.12688\/f1000research.16338.1 (2018).","DOI":"10.12688\/f1000research.16338.1"},{"key":"21064_CR60","first-page":"2579","volume":"9","author":"LJP van der Maaten","year":"2008","unstructured":"van der Maaten, L. J. P. & Hinton, G. E. Visualizing high-dimensional data using t-SNE. J. Mach. Learn. Res. 9, 2579\u20132605 (2008).","journal-title":"J. Mach. Learn. Res."},{"key":"21064_CR61","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"21064_CR62","unstructured":"Hansen, K. D. IlluminaHumanMethylationEPICanno.ilm10b2.hg19: annotation for Illumina\u2019s EPIC methylation arrays. R package version 0.6.0, https:\/\/bitbucket.com\/kasperdanielhansen\/Illumina_EPIC (2016)."},{"key":"21064_CR63","doi-asserted-by":"crossref","unstructured":"Martin, T. C., Yet, I., Tsai, P. C. & Bell, J. T. coMET: visualisation of regional epigenome-wide association scan results and DNA co-methylation patterns. BMC Bioinform. 16, 131 (2015).","DOI":"10.1186\/s12859-015-0568-2"},{"key":"21064_CR64","doi-asserted-by":"crossref","unstructured":"Gervin, K. et al. Systematic evaluation and validation of reference and library selection methods for deconvolution of cord blood DNA methylation data. Clin. Epigenetics 11, 125 (2019).","DOI":"10.1186\/s13148-019-0717-y"},{"key":"21064_CR65","doi-asserted-by":"crossref","unstructured":"Koestler, D. C. et al. Improving cell mixture deconvolution by identifying optimal DNA methylation libraries (IDOL). BMC Bioinform. 17, 120 (2016).","DOI":"10.1186\/s12859-016-0943-7"},{"key":"21064_CR66","unstructured":"Salas, L. A. &. Koestler, D. C. Illumina EPIC data on immunomagnetic sorted peripheral adult blood cells. R package version 1.5.3, https:\/\/github.com\/immunomethylomics\/FlowSorted.Blood.EPIC (2019)."},{"key":"21064_CR67","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/15592294.2016.1161875","volume":"11","author":"KM Bakulski","year":"2016","unstructured":"Bakulski, K. M. et al. DNA methylation of cord blood cell types: applications for mixed cell birth studies. Epigenetics 11, 354\u2013362 (2016).","journal-title":"Epigenetics"},{"key":"21064_CR68","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nmeth.3809","volume":"13","author":"E Rahmani","year":"2016","unstructured":"Rahmani, E. et al. Sparse PCA corrects for cell type heterogeneity in epigenome-wide association studies. Nat. Methods 13, 443\u2013445 (2016).","journal-title":"Nat. Methods"},{"key":"21064_CR69","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/bioinformatics\/btx059","volume":"33","author":"E Rahmani","year":"2017","unstructured":"Rahmani, E. et al. GLINT: a user-friendly toolset for the analysis of high-throughput DNA-methylation array data. Bioinformatics 33, 1870\u20131872 (2017).","journal-title":"Bioinformatics"},{"key":"21064_CR70","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.06.007","volume":"36","author":"M Labuhn","year":"2019","unstructured":"Labuhn, M. et al. Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome. Cancer Cell. 36, 123\u2013138.e10 (2019).","journal-title":"Cancer Cell."},{"key":"21064_CR71","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/bioinformatics\/btp373","volume":"25","author":"DC Koboldt","year":"2009","unstructured":"Koboldt, D. C. et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25, 2283\u20132285 (2009).","journal-title":"Bioinformatics"},{"key":"21064_CR72","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1158\/0008-5472.CAN-17-0337","volume":"77","author":"JT Robinson","year":"2017","unstructured":"Robinson, J. T., Thorvaldsdottir, H., Wenger, A. M., Zehir, A. & Mesirov, J. P. Variant review with the integrative genomics viewer. Cancer Res 77, e31\u2013e34 (2017).","journal-title":"Cancer Res"},{"key":"21064_CR73","doi-asserted-by":"crossref","unstructured":"Rahmani, E. et al. Genome-wide methylation data mirror ancestry information. Epigenetics Chromatin 10, 1 (2017).","DOI":"10.1186\/s13072-016-0108-y"},{"key":"21064_CR74","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1093\/bioinformatics\/bty892","volume":"35","author":"X Ren","year":"2019","unstructured":"Ren, X. & Kuan, P. F. methylGSA: a Bioconductor package and Shiny app for DNA methylation data length bias adjustment in gene set testing. Bioinformatics 35, 1958\u20131959 (2019).","journal-title":"Bioinformatics"},{"key":"21064_CR75","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/nbt1010-1045","volume":"28","author":"BE Bernstein","year":"2010","unstructured":"Bernstein, B. E. et al. The NIH Roadmap Epigenomics Mapping Consortium. Nat. Biotechnol. 28, 1045\u20131048 (2010).","journal-title":"Nat. Biotechnol."},{"key":"21064_CR76","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz, D. et al. Super-enhancers in the control of cell identity and disease. Cell 155, 934\u2013947 (2013).","journal-title":"Cell"},{"key":"21064_CR77","doi-asserted-by":"crossref","unstructured":"Peters, T. J. et al. De novo identification of differentially methylated regions in the human genome. Epigenetics Chromatin 8, 6 (2015).","DOI":"10.1186\/1756-8935-8-6"},{"key":"21064_CR78","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1093\/bioinformatics\/bts545","volume":"28","author":"BS Pedersen","year":"2012","unstructured":"Pedersen, B. S., Schwartz, D. A., Yang, I. V. & Kechris, K. J. Comb-p: software for combining, analyzing, grouping and correcting spatially correlated P-values. Bioinformatics 28, 2986\u20132988 (2012).","journal-title":"Bioinformatics"},{"key":"21064_CR79","doi-asserted-by":"publisher","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","volume":"47","author":"A Buniello","year":"2019","unstructured":"Buniello, A. et al. The NHGRI-EBI GWAS catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005\u2013D1012 (2019).","journal-title":"Nucleic Acids Res."},{"key":"21064_CR80","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1182\/blood-2008-04-152967","volume":"112","author":"O Tunstall-Pedoe","year":"2008","unstructured":"Tunstall-Pedoe, O. et al. Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations. Blood 112, 4507\u20134511 (2008).","journal-title":"Blood"},{"key":"21064_CR81","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nprot.2014.006","volume":"9","author":"S Picelli","year":"2014","unstructured":"Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 9, 171\u2013181 (2014).","journal-title":"Nat. Protoc."},{"key":"21064_CR82","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"21064_CR83","doi-asserted-by":"crossref","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","DOI":"10.1186\/s13059-014-0550-8"},{"key":"21064_CR84","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1182\/blood.2019001289","volume":"134","author":"S O\u2019Byrne","year":"2019","unstructured":"O\u2019Byrne, S. et al. Discovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programs. Blood 134, 1059\u20131071 (2019).","journal-title":"Blood"},{"key":"21064_CR85","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1542\/peds.2009-0913","volume":"125","author":"IE Olsen","year":"2010","unstructured":"Olsen, I. E., Groveman, S. A., Lawson, M. L., Clark, R. H. & Zemel, B. S. New intrauterine growth curves based on United States data. Pediatrics 125, e214\u2013e224 (2010).","journal-title":"Pediatrics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21064-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21064-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21064-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T10:37:23Z","timestamp":1669977443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21064-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["21064"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-21064-z","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]},"assertion":[{"value":"20 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"821"}}